AI leader 2021:
BenevolentAI combines the power of computational medicine and advanced AI to for early drug discovery to late-stage clinical development.
BenevolentAI have created their own AI/ML platform. This platform helps:
- Target identification to help find new ways of treating disease
- Molecular design to help new medicines
- Clinical mechanistic stratification to help understand how patients will respond to treatments
Their technology brings together, research and scientific experts to work side by side on better and faster ways to develop new medicines.
BenevolentAI AI technology is at the forefront of new drug discovery and empowering scientists to save lives. Great work.
BenevolentAI are based in London and Cambridge, UK
Check them out: Benevolent.com
The AI finder – AI LEADER 2021
During my AI, ML and data research, I often find the best companies and individuals today. I thought I would highlight them and share their technology and their story with you.